Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Altimmune, Inc.
Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021
Business
Aug 4 2021
4 min read

Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021

GAITHERSBURG, Md., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2021 financial results on Wednesday, August 11, 2021.

Altimmune management will host a conference call for investors beginning at 8:30 am E.T. to discuss the second quarter 2021 financial results and provide a business update.

Conference Call Information:

Date:Wednesday, August 11
Time: 8:30 am Eastern Time
Domestic Dial-in: (844) 615-6509
International Dial-in:(918) 922-3148
Conference ID: 9484516
Webcast:https://edge.media-server.com/mmc/p/ne5cqqtf

About AltimmuneAltimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (ALT-801), and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedInFollow @AltimmuneInc on Twitter

Investor and Media Contact:Will BrownChief Financial OfficerPhone: 240-654-1450wbrown@altimmune.com

Primary Logo

Source: Altimmune, Inc.